ClinVar Miner

Submissions for variant NM_001369.3(DNAH5):c.8030G>A (p.Arg2677Gln)

gnomAD frequency: 0.00001  dbSNP: rs886043448
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000369132 SCV000340209 uncertain significance not provided 2016-03-22 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000558292 SCV000624296 pathogenic Primary ciliary dyskinesia 2025-01-14 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 2677 of the DNAH5 protein (p.Arg2677Gln). This variant is present in population databases (no rsID available, gnomAD 0.005%). This missense change has been observed in individual(s) with primary ciliary dyskinesia (PMID: 24150548). ClinVar contains an entry for this variant (Variation ID: 286676). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DNAH5 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV000558292 SCV002681159 likely pathogenic Primary ciliary dyskinesia 2016-12-27 criteria provided, single submitter clinical testing The p.R2677Q variant (also known as c.8030G>A), located in coding exon 49 of the DNAH5 gene, results from a G to A substitution at nucleotide position 8030. The arginine at codon 2677 is replaced by glutamine, an amino acid with highly similar properties. This variant was detected in a homozygous individual with chronic rhinosinusitis, recurrent respiratory infections, bronchiectasis, and left-right laterality defects; her parents were confirmed heterozygous for this variant (Zhang J et al. Eur Arch Otorhinolaryngol, 2014 Jun;271:1589-94). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Fulgent Genetics, Fulgent Genetics RCV001257434 SCV005668850 likely pathogenic Primary ciliary dyskinesia 3 2024-04-16 criteria provided, single submitter clinical testing
Center for Molecular Medicine, Children’s Hospital of Fudan University RCV001257434 SCV001433991 likely pathogenic Primary ciliary dyskinesia 3 2020-07-07 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.